Treatment of advanced colorectal cancer with mitoxantrone, high dose folinic acid and fluorouracil

G. Comella, R. Casaretti, P. Comella, A. Daponte, A. Parziale, V. Iervolino, G. Santillo, D. Zarrilli

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A new combination chemotherapy including mitoxantrone 10 mg/m2 i.v. on day 1 and 5-fluorouracil 400 mg/m2 i.v. plus folinic acid 200 mg/m2 i.v. on days 1-5 was administered every 28 days to 13 patients with locally advanced or metastatic cocon (1 case), rectosigmoid colon (4 cases), or rectum (8 cases) carcinoma. The median number of cycles performed was 3 (range, 1-9). No patient achieved complete or partial remission with this regimen, whereas 5 showed a stable disease lasting 3-8 months. Acute toxicity was mild/moderate in intensity and comparable to that reported with the standard 5-fluorouracil + folinic acid combination. Since we observed no major responses in our 13 consecutive patients, we consider that the overall activity of our regimen, at the doses and schedule utilized, was only moderately effective in advanced colorectal carcinoma.

Original languageEnglish
Pages (from-to)445-446
Number of pages2
JournalTumori
Volume77
Issue number5
Publication statusPublished - 1991

Fingerprint

Mitoxantrone
Leucovorin
Fluorouracil
Colorectal Neoplasms
Combination Drug Therapy
Rectum
Appointments and Schedules
Colon
Therapeutics
Carcinoma

ASJC Scopus subject areas

  • Cancer Research

Cite this

Treatment of advanced colorectal cancer with mitoxantrone, high dose folinic acid and fluorouracil. / Comella, G.; Casaretti, R.; Comella, P.; Daponte, A.; Parziale, A.; Iervolino, V.; Santillo, G.; Zarrilli, D.

In: Tumori, Vol. 77, No. 5, 1991, p. 445-446.

Research output: Contribution to journalArticle

Comella, G, Casaretti, R, Comella, P, Daponte, A, Parziale, A, Iervolino, V, Santillo, G & Zarrilli, D 1991, 'Treatment of advanced colorectal cancer with mitoxantrone, high dose folinic acid and fluorouracil', Tumori, vol. 77, no. 5, pp. 445-446.
Comella, G. ; Casaretti, R. ; Comella, P. ; Daponte, A. ; Parziale, A. ; Iervolino, V. ; Santillo, G. ; Zarrilli, D. / Treatment of advanced colorectal cancer with mitoxantrone, high dose folinic acid and fluorouracil. In: Tumori. 1991 ; Vol. 77, No. 5. pp. 445-446.
@article{845a5fde41df46058a235c8360e0f18c,
title = "Treatment of advanced colorectal cancer with mitoxantrone, high dose folinic acid and fluorouracil",
abstract = "A new combination chemotherapy including mitoxantrone 10 mg/m2 i.v. on day 1 and 5-fluorouracil 400 mg/m2 i.v. plus folinic acid 200 mg/m2 i.v. on days 1-5 was administered every 28 days to 13 patients with locally advanced or metastatic cocon (1 case), rectosigmoid colon (4 cases), or rectum (8 cases) carcinoma. The median number of cycles performed was 3 (range, 1-9). No patient achieved complete or partial remission with this regimen, whereas 5 showed a stable disease lasting 3-8 months. Acute toxicity was mild/moderate in intensity and comparable to that reported with the standard 5-fluorouracil + folinic acid combination. Since we observed no major responses in our 13 consecutive patients, we consider that the overall activity of our regimen, at the doses and schedule utilized, was only moderately effective in advanced colorectal carcinoma.",
author = "G. Comella and R. Casaretti and P. Comella and A. Daponte and A. Parziale and V. Iervolino and G. Santillo and D. Zarrilli",
year = "1991",
language = "English",
volume = "77",
pages = "445--446",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "5",

}

TY - JOUR

T1 - Treatment of advanced colorectal cancer with mitoxantrone, high dose folinic acid and fluorouracil

AU - Comella, G.

AU - Casaretti, R.

AU - Comella, P.

AU - Daponte, A.

AU - Parziale, A.

AU - Iervolino, V.

AU - Santillo, G.

AU - Zarrilli, D.

PY - 1991

Y1 - 1991

N2 - A new combination chemotherapy including mitoxantrone 10 mg/m2 i.v. on day 1 and 5-fluorouracil 400 mg/m2 i.v. plus folinic acid 200 mg/m2 i.v. on days 1-5 was administered every 28 days to 13 patients with locally advanced or metastatic cocon (1 case), rectosigmoid colon (4 cases), or rectum (8 cases) carcinoma. The median number of cycles performed was 3 (range, 1-9). No patient achieved complete or partial remission with this regimen, whereas 5 showed a stable disease lasting 3-8 months. Acute toxicity was mild/moderate in intensity and comparable to that reported with the standard 5-fluorouracil + folinic acid combination. Since we observed no major responses in our 13 consecutive patients, we consider that the overall activity of our regimen, at the doses and schedule utilized, was only moderately effective in advanced colorectal carcinoma.

AB - A new combination chemotherapy including mitoxantrone 10 mg/m2 i.v. on day 1 and 5-fluorouracil 400 mg/m2 i.v. plus folinic acid 200 mg/m2 i.v. on days 1-5 was administered every 28 days to 13 patients with locally advanced or metastatic cocon (1 case), rectosigmoid colon (4 cases), or rectum (8 cases) carcinoma. The median number of cycles performed was 3 (range, 1-9). No patient achieved complete or partial remission with this regimen, whereas 5 showed a stable disease lasting 3-8 months. Acute toxicity was mild/moderate in intensity and comparable to that reported with the standard 5-fluorouracil + folinic acid combination. Since we observed no major responses in our 13 consecutive patients, we consider that the overall activity of our regimen, at the doses and schedule utilized, was only moderately effective in advanced colorectal carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0026334281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026334281&partnerID=8YFLogxK

M3 - Article

VL - 77

SP - 445

EP - 446

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 5

ER -